Asia-Pacific breast cancer diagnostics market is estimated to grow significantly at a CAGR of around 12.6% during the forecast period. The increasing prevalence rates and awareness programs by government and private organizations are also enabled in the growth of the market in Asia-Pacific. Breast cancer has emerged as a major health issue in various countries in Asia-Pacific. For instance, Australia is estimated to have the highest rate of breast cancer incidences in the region. The incidence rate of breast cancer in Australia was estimated to be around 86.0 per 100,000 women in 2015 as per Cancer Australia. Obesity, alcohol consumption and smoking are some of the major factors that are backing the increasing prevalence of breast cancer in the region that further contribute to the growth of the market.

Asia-Pacific breast cancer diagnostics market is segmented on the basis of technology and end-user. Based on technology, the market is further classified into mammography, biopsy, position emission tomography/Computed tomography, ultrasound, and others. The mammography segment is projected to hold the largest share in the market. Mammography is a specific medical imaging technique that uses a low-dose x-ray system to see inside the breasts. A mammography exam, called a mammogram, aids in the early detection and diagnosis of breast diseases in women. The introduction of new mammography technologies such as 3D mammography and others are the major driving factor of the breast cancer market. 3D mammography also called breast tomosynthesis and digital breast tomosynthesis (DBT). In this mammography, the multiple images of the breast from different angles are captured into a 3D image set. In this way, 3D breast imaging is similar to computed tomography (CT) imaging in which a series of thin "slices" are assembled together to create a 3D reconstruction of the body.  The end-user segment market is further segregated into hospitals and diagnostics centers. 

The companies which are contributing to the growth of the Asia-Pacific breast cancer diagnostics market include Agendia NV, Becton, Dickinson and Co., Danaher Corp., General Electric Co., Hologic Inc., Johnson & Johnson Services Inc., Myriad Genetics, Inc., NanoString Technologies, Inc., Koninklijke Philips N.V., Siemens Healthcare GmbH, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, and technological advancements to stay competitive in the market. 

Research Methodology

The market study of Asia-Pacific breast cancer diagnostics market is incorporated by extensive primary and secondary research conducted by the research team.  Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

Market Segmentation

1. Asia-Pacific breast cancer diagnostics Market Research and Analysis by Technology
2. Asia-Pacific breast cancer diagnostics Market Research and Analysis by End-User

The Report Covers

• Comprehensive research methodology of the Asia-Pacific breast cancer diagnostics market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the Asia-Pacific breast cancer diagnostics market.
• Insights about market determinants which are stimulating the Asia-Pacific breast cancer diagnostics market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.